3.000USD-1.96%Mkt Cap: 27.78M USDP/E: —Last update: 2026-05-26
CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered s…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
106.49BDKKP/E 20.5
66.47BUSDP/E 15.5
46.51BEURP/E 30.5
43.17BEURP/E 35.9
39.41BUSDP/E 74.0
32.84BUSD—
31.18BSEKP/E 46.1
Indicators:|
Key Statistics
Company
Market Cap27.78M USD
Enterprise Value15.69M USD
Revenue (TTM)2.09M USD
Gross Profit-19.73M USD
Net Income (TTM)-26.97M USD
Revenue/Share0.2280 USD
Last Price3.000 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees15
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.51
PEG—
EV/EBITDA—
EV/Revenue7.51
P/S13.70
P/B2.69
EPS (TTM)-3.28
EPS (Forward)-2.05
52W Range
2.8202% of range13.13
52W High13.13 USD
52W Low2.820 USD
Profitability
Gross Margin0.00%
Oper. Margin-1488.86%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-147.98%
ROA-117.87%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-23.45M USD
CapEx (TTM)—
FCF Margin-779.90%
FCF Yield-58.66%
Net Debt-12.92M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio3.36
Quick Ratio2.87
Book Value/Sh1.147 USD
Cash/Share1.396 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateDec 14, 2018
Splits
Last Split2:3
Split DateAug 17, 2023
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)21.86 USD
Target Range9.000 USD – 31.00 USD
# Analysts7
Ownership
Shares Out.9.26M
Float6.29M
Insiders32.84%
Institutions19.43%
Short Interest
Short Ratio7.5d
Short % Float4.40%
Short % Out.3.04%
Shares Short281.91K
Short (prev mo.)313.49K
Technical
SMA 503.858 (-22.2%)
SMA 2006.632 (-54.8%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)56.55K
Avg Vol (10d)75.66K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—